MeSH tree: C01.221.250.500
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life, according to a new Cornell University study. The longer the delay, the study found, ...
Apr 27, 2026
0
18
Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, including chronic liver disease. Despite longstanding recommendations for prenatal screening, an estimated ...
Apr 27, 2026
0
8
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver cancer in nearly a million ...
Apr 22, 2026
0
8
Chronic hepatitis B is substantially prevalent across the European Union and European Economic Area (EU/EEA), affecting an estimated 0.7% of the population in the region in 2022, according to a new study published in Eurosurveillance. ...
Apr 13, 2026
0
2
A recently released prospective analysis of the first eight years of the Johns Hopkins Medicine-led Zero TB in Kids program shows that significant reduction of tuberculosis (TB) transmission and burden (the total impact of ...
Mar 24, 2026
0
3
Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and hepatocellular cancer (HCC, liver cancer). It affects approximately 296 million people worldwide. Hepatitis ...
Mar 2, 2026
0
7
Hepatitis B vaccination at birth is safe and effective compared with a delayed first dose, according to research published online Feb. 5 in Pediatrics.
Feb 11, 2026
0
5
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis and treatment in hard-to-reach ...
Feb 8, 2026
0
12
A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face substantially higher risks of kidney dysfunction than those living with HIV alone.
Jan 14, 2026
0
11
The new foot-and-mouth disease vaccine developed by researchers at Diamond Light Source is projected to deliver over $1.3 billion in annual benefits and transform global livestock resilience.
Jan 13, 2026
0
17
